{"id":229217,"date":"2021-09-30T09:51:00","date_gmt":"2021-09-30T07:51:00","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=229217"},"modified":"2021-09-30T13:15:56","modified_gmt":"2021-09-30T11:15:56","slug":"farmacies-ajudem-voluntariament-investigacio-covid-19","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/","title":{"rendered":"Les farm\u00e0cies ajudem en la investigaci\u00f3 de noves l\u00ednies de defensa contra la Covid-19"},"content":{"rendered":"\n<h6 class=\"wp-block-heading\"><strong><em>A l&#8217;agost i de forma estiuenca, FEFAC continua ampliant la col\u00b7laboraci\u00f3 en la lluita contra la Covid-19, ara amb l&#8217;assaig cl\u00ednic de la Fundaci\u00f3 Lluita contra la Sida i les Malalties Infeccioses<\/em>. <em>En la fotografia, Antoni Torres, president de FEFAC, i el doctor Oriol Mitj\u00e0, professor associat de la Fundaci\u00f3 Lluita contra la Sida i les Malalties Infeccioses.<\/em><\/strong><\/h6>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Des de FEFAC us proposem col\u00b7laborar a informar sobre un estudi destinat a avaluar l&#8217;efic\u00e0cia de les immunoglobulines hiperimmunes covid <\/h2>\n\n\n\n<p>La <em><strong><a href=\"https:\/\/www.flsida.org\/es\/quien-es-somos\">Fundaci\u00f3 Lluita contra la Sida I les Malalties Infeccioses<\/a><\/strong> <\/em>ha posat en marxa un <strong>assaig cl\u00ednic <\/strong>destinat a avaluar l\u2019efic\u00e0cia de la immunoglobulina C19-IG 20% de la companyia <strong>Grifols<\/strong> (immunoglobulines hiperimmunes covid). La C19-IG 20% \u00e9s una immunoglobulina humana preparada per l\u2019administraci\u00f3 subcut\u00e0nia que segueix un proc\u00e9s de fabricaci\u00f3 molt similar al Xembify\u00ae, que en aquest cas est\u00e0 elaborada a partir del plasma de donant convalescent que s\u2019ha recuperat de la COVID-19.<\/p>\n\n\n\n<p>L\u2019estudi compta amb la <strong>col\u00b7laboraci\u00f3 de l\u2019ICS I les Direccions d\u2019Atenci\u00f3 Prim\u00e0ria de les Regions de Catalunya Central, Metropolitana Nord, Metropolitana Sud i Barcelona<\/strong>. El personal d\u2019investigaci\u00f3 s\u00f3n part de l\u2019equip dels doctors <strong>Oriol Mitj\u00e0 I Bonaventura Clotet <\/strong>de l\u2019<strong>Hospital Germans Trias<\/strong>. Est\u00e0 previst que participin en l\u2019estudi un total de 800 persones.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Tipus de perfil que busquen els investigadors<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>Els investigadors busquen persones:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Amb infecci\u00f3 recentment confirmada per SARS-CoV-2<\/strong><\/li><li><strong>Asimptom\u00e0tiques<\/strong><\/li><li><strong>De 18 anys o m\u00e9s<\/strong><\/li><li><strong>&nbsp;no vacunades (cap dosi).<\/strong><\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Des de la FEFAC us animem a participar en benefici de tots<\/strong><\/h2>\n\n\n\n<p>Des de la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya creiem que les farm\u00e0cies, com a centre sanitari m\u00e9s proper, accessible i m\u00e9s capil\u00b7lar en el territori, i el farmac\u00e8utic com a professional sanitari m\u00e9s freq\u00fcentat i de confian\u00e7a, <strong>podem col\u00b7laborar amb els investigadors a informar sobre l\u2019estudi a possibles candidats a participar-hi.<\/strong><\/p>\n\n\n\n<p>Us proposem informar, mitjan\u00e7ant la <strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2021\/08\/RECLUTAMIENTO-ESTUDIO-INMUNOGLOBULINA-ANTICOVID_FARMACIAS-cat.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">NOTA ADJUNTA<\/a><\/span><\/em><\/strong>, a les persones que dispensem tests d&#8217;ant\u00edgens, majors de 18 anys, no vacunades, i que si en fer-lo resulta positiu, poden participar en aquest estudi cl\u00ednic, contactant amb els investigadors. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Per qu\u00e8 \u00e9<\/strong><strong>s important aquest assaig?<\/strong><\/h2>\n\n\n\n<p>Les vacunes s\u00f3n un aven\u00e7 formidable, per\u00f2 no tothom pot rebre-les. Les persones amb sistemes immunitaris febles tenen m\u00e9s risc de contraure la malaltia, per\u00f2 no poden vacunar-se. Les persones amb leuc\u00e8mia o limfoma, o amb malaltia inflamat\u00f2ria intestinal, entre d\u2019altres, poden rebre la vacuna, per\u00f2 sense que aquesta resulti prou efica\u00e7.<\/p>\n\n\n\n<p>Ara que les persones m\u00e9s vulnerables estan ja protegides, cal identificar una segona l\u00ednia de defensa contra la COVID-19 per aquells casos <strong>en els quals la vacuna no funciona, o mentre no arriba a tothom.<\/strong><\/p>\n\n\n\n<p>D\u2019anticossos existeix ja tractament monoclonal, per\u00f2 \u00e9s possible que les variants del virus escapin al tractament, i d\u2019aqu\u00ed l\u2019import\u00e0ncia d\u2019aquest estudi, donat que en ser immunoglobulines aporten anticossos policlonals que dificulten la fuita del virus al tractament.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-white-color has-vivid-red-background-color has-text-color has-background\" href=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2021\/08\/RECLUTAMIENTO-ESTUDIO-INMUNOGLOBULINA-ANTICOVID_FARMACIAS-cat.pdf\"><strong> NOTA ADJUNTA<\/strong><\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Fundaci\u00f3 Lluita contra la Sida I les Malalties Infeccioses ha posat en marxa un assaig cl\u00ednic destinat a avaluar l\u2019efic\u00e0cia de la immunoglobulina C19-IG 20% de la companyia Grifols. La C19-IG 20% \u00e9s una immunoglobulina humana preparada per l\u2019administraci\u00f3 subcut\u00e0nia que segueix un proc\u00e9s de fabricaci\u00f3 molt similar al Xembify\u00ae, que en aquest cas est\u00e0 elaborada a partir del plasma de donant convalescent que s\u2019ha recuperat de la COVID-19.<\/p>\n","protected":false},"author":2313,"featured_media":229222,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2251,2245,2066,10,11,12,13,2270,14,15,251,101],"tags":[85,1070,1587,1790,2244],"class_list":["post-229217","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-informacio-sanitaria-organitzativa","category-covid-19","category-categoria-actualitat","category-empresarials","category-fefac","category-afb","category-afet","category-implicacio-social","category-afell","category-agfe","category-reflexions-de-junta","category-sanitaria","tag-fefac","tag-investigacio","tag-estiu","tag-noticies","tag-covid-19"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Les farm\u00e0cies ajudem en investigaci\u00f3 de l\u00ednies de defensa contra la Covid<\/title>\n<meta name=\"description\" content=\"Fundaci\u00f3 Lluita contra la Sida I les Malalties Infeccioses posa en marxa un assaig per avaluar l\u2019efic\u00e0cia de la immunoglobulina hiperinmune anticovid\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les farm\u00e0cies ajudem en investigaci\u00f3 de l\u00ednies de defensa contra la Covid\" \/>\n<meta property=\"og:description\" content=\"Fundaci\u00f3 Lluita contra la Sida I les Malalties Infeccioses posa en marxa un assaig per avaluar l\u2019efic\u00e0cia de la immunoglobulina hiperinmune anticovid\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-30T07:51:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-30T11:15:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2021\/08\/toni-torres-omitja-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"Les farm\u00e0cies ajudem en la investigaci\u00f3 de noves l\u00ednies de defensa contra la Covid-19\",\"datePublished\":\"2021-09-30T07:51:00+00:00\",\"dateModified\":\"2021-09-30T11:15:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/\"},\"wordCount\":532,\"commentCount\":1,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/toni-torres-omitja-2.jpg\",\"keywords\":[\"FEFAC\",\"investigaci\u00f3\",\"estiu\",\"not\u00edcies\",\"covid-19\"],\"articleSection\":[\"Informaci\u00f3 sanit\u00e0ria i organitzativa\",\"COVID-19\",\"Actualitat\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"Implicaci\u00f3 social\",\"AFELL\",\"AGFE\",\"Reflexions de Junta\",\"Sanit\u00e0ria\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/\",\"name\":\"Les farm\u00e0cies ajudem en investigaci\u00f3 de l\u00ednies de defensa contra la Covid\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/toni-torres-omitja-2.jpg\",\"datePublished\":\"2021-09-30T07:51:00+00:00\",\"dateModified\":\"2021-09-30T11:15:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"Fundaci\u00f3 Lluita contra la Sida I les Malalties Infeccioses posa en marxa un assaig per avaluar l\u2019efic\u00e0cia de la immunoglobulina hiperinmune anticovid\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/toni-torres-omitja-2.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/toni-torres-omitja-2.jpg\",\"width\":1024,\"height\":640},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/farmacies-ajudem-voluntariament-investigacio-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les farm\u00e0cies ajudem en la investigaci\u00f3 de noves l\u00ednies de defensa contra la Covid-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les farm\u00e0cies ajudem en investigaci\u00f3 de l\u00ednies de defensa contra la Covid","description":"Fundaci\u00f3 Lluita contra la Sida I les Malalties Infeccioses posa en marxa un assaig per avaluar l\u2019efic\u00e0cia de la immunoglobulina hiperinmune anticovid","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/","og_locale":"ca_ES","og_type":"article","og_title":"Les farm\u00e0cies ajudem en investigaci\u00f3 de l\u00ednies de defensa contra la Covid","og_description":"Fundaci\u00f3 Lluita contra la Sida I les Malalties Infeccioses posa en marxa un assaig per avaluar l\u2019efic\u00e0cia de la immunoglobulina hiperinmune anticovid","og_url":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/","og_site_name":"FEFAC","article_published_time":"2021-09-30T07:51:00+00:00","article_modified_time":"2021-09-30T11:15:56+00:00","og_image":[{"width":1024,"height":640,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2021\/08\/toni-torres-omitja-2.jpg","type":"image\/jpeg"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"Les farm\u00e0cies ajudem en la investigaci\u00f3 de noves l\u00ednies de defensa contra la Covid-19","datePublished":"2021-09-30T07:51:00+00:00","dateModified":"2021-09-30T11:15:56+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/"},"wordCount":532,"commentCount":1,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2021\/08\/toni-torres-omitja-2.jpg","keywords":["FEFAC","investigaci\u00f3","estiu","not\u00edcies","covid-19"],"articleSection":["Informaci\u00f3 sanit\u00e0ria i organitzativa","COVID-19","Actualitat","Empresarials","FEFAC","AFB","AFET","Implicaci\u00f3 social","AFELL","AGFE","Reflexions de Junta","Sanit\u00e0ria"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/","url":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/","name":"Les farm\u00e0cies ajudem en investigaci\u00f3 de l\u00ednies de defensa contra la Covid","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2021\/08\/toni-torres-omitja-2.jpg","datePublished":"2021-09-30T07:51:00+00:00","dateModified":"2021-09-30T11:15:56+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"Fundaci\u00f3 Lluita contra la Sida I les Malalties Infeccioses posa en marxa un assaig per avaluar l\u2019efic\u00e0cia de la immunoglobulina hiperinmune anticovid","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2021\/08\/toni-torres-omitja-2.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2021\/08\/toni-torres-omitja-2.jpg","width":1024,"height":640},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/farmacies-ajudem-voluntariament-investigacio-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Les farm\u00e0cies ajudem en la investigaci\u00f3 de noves l\u00ednies de defensa contra la Covid-19"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/229217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=229217"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/229217\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/229222"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=229217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=229217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=229217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}